Acurx Pharmaceuticals, Inc
Price
FilingsNewest: 424B3, ProspectusSep 17 →InsidersNo open-market buys or sales.→HoldersVanguard 0.7%Geode 0.6%Vanguard Fiduciary Trust 0.3%→PeersClosest companies: MCRB, TOVX, BHVN→
From the filings
Figures
- Net income
- −$7.5Mlast 12 months
- Operating cash flow
- −$6.1Mlast 12 months
- Cash and equivalents
- $10.7Mat the last balance sheet
- Shares outstanding
- 4.7M shareson issue